Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Biochemical Pharmacology
|
January 18, 2006
Glycopeptides: Update on an old successful antibiotic class
John L Pace, Guang Yang
Bioorganic & Medicinal Chemistry Letters
|
November 19, 2003
Semi-synthetic glycopeptide antibacterials
J Kevin Judice, John L Pace
Current Opinion in Investigational Drugs (London, England : 2000)
|
March 9, 2005
Telavancin (Theravance)
John L Pace, J Kevin Judice
Bioorganic & Medicinal Chemistry Letters
|
January 27, 2004
Vancomycin disulfide derivatives as antibacterial agents
YongQi Mu, Matthew Nodwell, John L Pace, et al.
Cold Spring Harbor Perspectives in Medicine
|
September 25, 2016
Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance
Daina Zeng, Dmitri Debabov, Theresa L Hartsell, et al.
Antimicrobial Agents and Chemotherapy
|
October 25, 2003
In vitro activity of TD-6424 against Staphylococcus aureus
John L Pace, Kevin Krause, Deborah Johnston, et al.
Vaccine
|
July 12, 2005
Prevention of disease in ferrets fed an inactivated whole cell Campylobacter jejuni vaccine
Donald H Burr, David Rollins, Lanfong H Lee, et al.
The Journal of Antibiotics
|
January 27, 2009
A multivalent approach to drug discovery for novel antibiotics
Daniel D Long, James B Aggen, Burton G Christensen, et al.
Journal of the American Chemical Society
|
June 6, 2003
Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers
John H Griffin, Martin S Linsell, Matthew B Nodwell, et al.
The Journal of Antibiotics
|
January 27, 2009
Exploring the positional attachment of glycopeptide/beta-lactam heterodimers
Daniel D Long, James B Aggen, Jason Chinn, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Biochemical Pharmacology
|
January 18, 2006
Glycopeptides: Update on an old successful antibiotic class
John L Pace, Guang Yang
Bioorganic & Medicinal Chemistry Letters
|
November 19, 2003
Semi-synthetic glycopeptide antibacterials
J Kevin Judice, John L Pace
Current Opinion in Investigational Drugs (London, England : 2000)
|
March 9, 2005
Telavancin (Theravance)
John L Pace, J Kevin Judice
Bioorganic & Medicinal Chemistry Letters
|
January 27, 2004
Vancomycin disulfide derivatives as antibacterial agents
YongQi Mu, Matthew Nodwell, John L Pace, et al.
Cold Spring Harbor Perspectives in Medicine
|
September 25, 2016
Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance
Daina Zeng, Dmitri Debabov, Theresa L Hartsell, et al.
Antimicrobial Agents and Chemotherapy
|
October 25, 2003
In vitro activity of TD-6424 against Staphylococcus aureus
John L Pace, Kevin Krause, Deborah Johnston, et al.
Vaccine
|
July 12, 2005
Prevention of disease in ferrets fed an inactivated whole cell Campylobacter jejuni vaccine
Donald H Burr, David Rollins, Lanfong H Lee, et al.
The Journal of Antibiotics
|
January 27, 2009
A multivalent approach to drug discovery for novel antibiotics
Daniel D Long, James B Aggen, Burton G Christensen, et al.
Journal of the American Chemical Society
|
June 6, 2003
Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers
John H Griffin, Martin S Linsell, Matthew B Nodwell, et al.
The Journal of Antibiotics
|
January 27, 2009
Exploring the positional attachment of glycopeptide/beta-lactam heterodimers
Daniel D Long, James B Aggen, Jason Chinn, et al.
Page
of 2